Huang, Shaoying
Zheng, Fengping
Lin, Hua
Zhou, Xianqing
Xu, Huixuan
Zhang, Cantong
Dai, Weier
Hocher, Berthold
Zhang, Xinzhou
Tang, Donge
Dai, Yong https://orcid.org/0000-0002-6840-9158
Funding for this research was provided by:
Natural Science Foundation of Guangxi Province (Grant No. 2017GXNSFAA198375)
the science and technology plan of Shenzhen (No. JCYJ20170307095606266)
Guangxi Key Laboratory of Metabolic Diseases Research (2017-181h-03)
the National Natural Science Foundation of China (Grant No. 81671596)
the National Science Foundation for Young Scientists of China (Grant No. 31700795)
Article History
Received: 20 January 2020
Accepted: 15 January 2021
First Online: 8 February 2021
Ethics approval and consent to participate
: The study protocol and all procedures were approved by the Medical Ethics Committee of Shenzhen People’s Hospital (No. LL-KY-2019366) and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. Informed consent was obtained from all individual participants included in the study.
: We agree for publication upon acceptance and we agree that all copyright ownership for the article is transferred to—Clinical Proteomics (ISSN: 1559‑0275). The material submitted is new, original and has not been submitted to another journal for concurrent consideration.
: On behalf of all authors, the corresponding author states that there is no competing interests.